Chinese Medical Journal study reports on the sex disparity and global temporal trends in the disease burden of urolithiasis
Peer-Reviewed Publication
Updates every hour. Last Updated: 9-Oct-2025 00:11 ET (9-Oct-2025 04:11 GMT/UTC)
Urolithiasis is rising in prevalence, imposing a significant healthcare burden globally. Researchers from China analyzed global health database to reveal increase in total incidence and mortality from urolithiasis over the last 30 years. Age-standardized incidence and mortality rates were higher in males, particularly in countries with low socio-economic development. Notably, China has succeeded in reducing incidence rates of urolithiasis, and insights from their strategies will strengthen measures to reduce the disease burden in vulnerable regions.
A team of scientists at the Garvan Institute of Medical Research has discovered that inactivation of a stress pathway makes ER+ breast cancer cells ignore stress signals, allowing them to evade treatment.
The Physicians Committee for Responsible Medicine, a nonprofit national medical ethics group, applauds Colorado State University for its decision to shutter a nutrition study for which the university had approved the killing of 17,766 animals. The study, funded by the U.S. Department of Agriculture and the university, claimed to investigate the effect of legumes on the human gut microbiome. Public records reveal the primary investigator had to date used 1,587 mice.
Hundreds of thousands of people undergo corrective eye surgeries each year, including the laser-assisted technique known as LASIK. But the procedure involves cutting away tissue, which can result in negative side effects, prompting researchers to develop a less invasive technique that takes the laser out of LASIK by remodeling cornea tissue, rather than removing it, in initial animal tissue tests. The researchers will present their results at ACS Fall 2025.
Acetaminophen overdose is the leading cause of acute liver injury in the U.S. Now, researchers propose that a new molecule has the potential to treat acetaminophen-induced liver injury (AILI) and other inflammatory conditions. As demonstrated in their small-scale AILI mouse study, the small molecule decreased liver inflammation and prevented further liver damage. The researchers will present their results at ACS Fall 2025.